Zengbao Lin1, Huiqin Bian1, Chaoyuan Chen1, Wenling Chen2, Qiong Li3. 1. Department of Digestive Endoscopy, the Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fujian, China. 2. Department of Traditional Medicine, the Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fujian, China. 3. Department of Preventive Treatment, the Affiliated People's Hospital of Fujian University of Traditional Chinese Medicine, Fujian, China.
Abstract
BACKGROUND: Gastric cancer is a common malignant tumor. The aim of the present study was to analyze the application value of serum pepsinogen (PG), carbohydrate antigen 72-4 (CA72-4), and gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer. METHODS: In total, 122 patients with gastric cancer treated in our hospital from January 2018 to January 2021 were selected as the gastric cancer group and subdivided into the early gastric cancer (group A) and advanced gastric cancer (group B) groups. Sixty-five patients with benign gastric disease treated in the same hospital during the same period were selected as the control group, and 122 healthy people who underwent physical examination during the same period were allocated to the control group. The differences in the levels of G-17, PGI, PGII, PGI/PGII, and CA72-4 were compared; receiver-operating characteristic curves were drawn; and the efficacy of different factors in the diagnosis of early gastric cancer was calculated. RESULTS: G-17, PGI, and PGI/PGII levels in the gastric cancer group were significantly lower than those in the healthy group, and CA72-4 was significantly higher than that in the healthy group (P<0.05), but there was no significant difference in PGII between the 2 groups (P>0.05). G-17, PGI, and PGI/PGII levels in groups A and B were significantly lower than those in the control group. CA72-4 in groups A and B was significantly higher than that of the control group, and was highest in group B (P<0.05). The areas under the curve (AUC) of G-17, PGI, PGI/PGII, and CA72-4 were 0.671, 0.726, 0.769, and 0.602, respectively, and the AUC of combined detection was 0.883, which was significantly higher than that of single detection. CONCLUSIONS: Serum PG, CA72-4 combined with G-17 detection has high sensitivity and specificity in the screening and diagnosis of early gastric cancer, and has high clinical application value. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
BACKGROUND: Gastric cancer is a common malignant tumor. The aim of the present study was to analyze the application value of serum pepsinogen (PG), carbohydrate antigen 72-4 (CA72-4), and gastrin-17 (G-17) detection in the screening, diagnosis, and evaluation of early gastric cancer. METHODS: In total, 122 patients with gastric cancer treated in our hospital from January 2018 to January 2021 were selected as the gastric cancer group and subdivided into the early gastric cancer (group A) and advanced gastric cancer (group B) groups. Sixty-five patients with benign gastric disease treated in the same hospital during the same period were selected as the control group, and 122 healthy people who underwent physical examination during the same period were allocated to the control group. The differences in the levels of G-17, PGI, PGII, PGI/PGII, and CA72-4 were compared; receiver-operating characteristic curves were drawn; and the efficacy of different factors in the diagnosis of early gastric cancer was calculated. RESULTS: G-17, PGI, and PGI/PGII levels in the gastric cancer group were significantly lower than those in the healthy group, and CA72-4 was significantly higher than that in the healthy group (P<0.05), but there was no significant difference in PGII between the 2 groups (P>0.05). G-17, PGI, and PGI/PGII levels in groups A and B were significantly lower than those in the control group. CA72-4 in groups A and B was significantly higher than that of the control group, and was highest in group B (P<0.05). The areas under the curve (AUC) of G-17, PGI, PGI/PGII, and CA72-4 were 0.671, 0.726, 0.769, and 0.602, respectively, and the AUC of combined detection was 0.883, which was significantly higher than that of single detection. CONCLUSIONS: Serum PG, CA72-4 combined with G-17 detection has high sensitivity and specificity in the screening and diagnosis of early gastric cancer, and has high clinical application value. 2021 Journal of Gastrointestinal Oncology. All rights reserved.
Entities:
Keywords:
Serum pepsinogen (serum PG); carbohydrate antigen 72-4 (CA72-4); early gastric cancer; gastric cancer screening; gastrin-17 (G-17)
Authors: Kyung Hwa Shin; Hyung Hoi Kim; Byung Su Kwon; Dong Soo Suh; Jong Kil Joo; Ki Hyung Kim Journal: Ann Lab Med Date: 2020-01 Impact factor: 3.464
Authors: Daphne S Bakker; Lieneke F M Ariens; Barbara Giovannone; DirkJan Hijnen; Eveline M Delemarre; Edward Knol; Stefan Nierkens; Marjolein S de Bruin-Weller; Judith L Thijs; Julia Drylewicz Journal: Allergy Date: 2020-07-24 Impact factor: 13.146